CYTOO's Partner Astellas Gene Therapies Has Presented Results of an AGT/CYTOO Collaboration on Clinical Candidate Selection to Treat DMD at the 2nd Gene Therapy for Muscular Disorders Summit
CYTOO and Astellas Gene Therapies (AGT) entered into a research collaboration in 2020 to select AGT's AAV gene therapy clinical candidate to treat Duchenne Muscular Dystrophy (DMD). The results of this
United States Luc Selig Florence Portejoie Astellas Gene Therapies Duchenne Muscular Dystrophy Gene Therapy
Source: finanznachrichten.de